| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 41.00K | $ -942.00K | $ 200.00K | $ 75.00K |
| Gross Profit | $ -88.76K | $ 41.00K | $ -942.00K | $ 200.00K | $ 75.00K |
| Operating Income | $ -461.13K | $ -581.00K | $ -1.73M | $ -615.00K | $ -893.00K |
| EBITDA | $ -207.83K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Income | $ -147.22K | $ -575.00K | $ -1.77M | $ -1.01M | $ -766.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.88M | $ 884.00K | $ 1.55M | $ 2.21M | $ 4.25M |
| Total Assets | $ 8.04M | $ 7.65M | $ 8.25M | $ 10.02M | $ 11.06M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -2.88M | $ -884.00K | $ -1.55M | $ -2.21M | $ -4.25M |
| Total Liabilities | $ 187.04K | $ 112.00K | $ 142.00K | $ 139.00K | $ 175.00K |
| Stockholders' Equity | $ 6.32M | $ 7.54M | $ 8.11M | $ 9.88M | $ 10.89M |
| Cash Flow | |||||
| Free Cash Flow | $ -368.04K | $ -639.00K | $ -609.00K | $ -1.30M | $ -903.00K |
| Operating Cash Flow | $ -368.04K | $ -639.00K | $ -609.00K | $ -1.30M | $ -903.00K |
| Investing Cash Flow | $ 1.98M | $ -24.00K | $ -50.00K | $ -750.00K | $ -2.80M |
| Financing Cash Flow | $ 554.22K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
Imed Pu Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.